Novavax Inc. (NVAX)

3.69
NASDAQ : Health Technology
Prev Close 3.75
Day Low/High 3.69 / 3.81
52 Wk Low/High 3.70 / 51.60
Avg Volume 634.70K
Exchange NASDAQ
Shares Outstanding 26.58M
Market Cap 99.67M
EPS -10.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Novavax's Chart Looked Good, Until It Didn't

Novavax's Chart Looked Good, Until It Didn't

Things were looking up and then today happened.

Look to Costamare for Value in Shipping

Look to Costamare for Value in Shipping

It's safe to say these guys know what they are doing.

The Good, The Bad And The Ugly

"Such ingratitude, after all the times I saved your life." -- Blondie, THE GOOD THE BAD THE UGLY Let's run down the good, the bad and the ugly in today's market so far: THE GOOD Bonds are trading better today. The 10- and 30-year bond yields are dow...

Underlying Risks in Speculative Bio Techs Can't Be Overstated

I have followed Novavax for several years.   After yesterday's market close the company announced the results of their Phase Three trial for a respiratory-virus drug. NVAX missed its goal, and the shares are trading down by about 80% ($8.40 to $1) i...

Novavax downgraded at JP Morgan

Novavax downgraded at Piper

Novavax downgraded at Wedbush

Bought Aerie Earlier? Congratulations

Bought Aerie Earlier? Congratulations

An update on some recent small biotech recommendations.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

4 Biotechs Set to Provide a Shot in the Arm

4 Biotechs Set to Provide a Shot in the Arm

Each company has approaching catalysts.

3 Biotech-Investing Mistakes to Avoid

3 Biotech-Investing Mistakes to Avoid

These are the biggest errors that I've made over the years.

4 Small-Cap Biotechs With Big Stories to Tell

4 Small-Cap Biotechs With Big Stories to Tell

Watch these names as stability returns to the sector.

My Takeaways and Observations

Another strong market day.  The issue of taxes was front and center today. Here are some of my takes: My Take on Corporate Taxes  Man Up, Allergan Shareholders  Who Loses in Pfizer/Allergan Deal's Demise?  I remain manifestly bearish, in the belief ...

Buying Biotechs

The iShares Nasdaq Biotechnology ETF (IBB) has tumbled from nearly $400 a share early last summer to around $240 at last check, so I'm taking advantage of today's market schmeissing to purchase a small position in a biotech (biowreck?). I'm buying a...

Jim Cramer Still Likes Home Depot, Kroger, But Tough to Buy Them Now

Jim Cramer Still Likes Home Depot, Kroger, But Tough to Buy Them Now

Jim Cramer talks oil, Citigroup, burger joints and biotechs.

Market Wrap: Stocks Retreat on China Devaluation

Market Wrap: Stocks Retreat on China Devaluation

However, utilities and some technology names bucked the trend.

Twelve Posts of Christmas, Part 4

Twelve Posts of Christmas, Part 4

Piper's best stock picks, and some festive drinks.

Forget Calling a Bottom

Just be patient and protect capital.

Two Speculative Biotech Stocks

Two Speculative Biotech Stocks

InterMune, Novavax have promising products and acquisition possibilities.

Sifting Through Small-Caps

Sifting Through Small-Caps

These smaller companies with recent insider buying look intriguing.

Considering a Few Small-Cap Biotech Plays

Considering a Few Small-Cap Biotech Plays

The best way to invest in this sector is to accumulate small positions in at least a dozen firms.